Cancer
Malignant Bladder Neoplasm
CI-CAN-00005866Explore in graph →
Top-level346 active trials10 approved drugs25 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005866Explore in graph →
Clinical trials
1,510 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (179)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00553566 | Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer | unknown | — | 1,600 | University of BirminghamOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00054626 | Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer | unknown | Phase 3 | 700 | Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, ItalyOTHER_GOV | 1 | Dec 18, 2013 |
| clinicaltrials |
| NCT00005958 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer | unknown | Phase 2 | — | AmgenINDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00003725 | Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer | unknown | Phase 3 | 300 | Anthra PharmaceuticalsINDUSTRY | 2 | Nov 6, 2013 | clinicaltrials |
| NCT01968928 | The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma | unknown | — | 25 | National Taiwan University HospitalOTHER | 1 | Oct 28, 2013 | clinicaltrials |
| NCT00757614 | Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom | unknown | — | 14,000 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01124682 | 3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder | unknown | Phase 1 | 60 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01094964 | Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer | unknown | Phase 3 | 242 | Cancer Research Campaign Clinical Trials CentreOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01222676 | Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder | unknown | Phase 2 | 45 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01118039 | Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer | unknown | Phase 2 | 41 | Hospital del MarOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT01826565 | Comparison of Two Insertion Technique of I-gel(I-gel90) | unknown | N/A | 100 | Seoul National University HospitalOTHER | 0 | May 6, 2013 | clinicaltrials |
| NCT01814150 | The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel | unknown | — | 200 | Gottfried MayaOTHER | 1 | Mar 25, 2013 | clinicaltrials |
| NCT01698359 | Evaluation of Ultrasound Probe for Use in Bladder Radiotherapy | unknown | — | 5 | University Hospital Birmingham NHS Foundation TrustOTHER | 1 | Oct 3, 2012 | clinicaltrials |
| NCT01542567 | Efficacy of Diclofenac BCG Irrigations(DIC-2011) | unknown | Phase 3 | 100 | Carmel Medical CenterOTHER | 0 | May 22, 2012 | clinicaltrials |
| NCT00959868 | A Study for Treatment of Superficial Bladder Cancer Using OGX-427 | unknown | Phase 1 | 36 | Vancouver Coastal HealthOTHER_GOV | 1 | Feb 13, 2012 | clinicaltrials |
| NCT01198808 | Tumorspecific T-cell Immunity in Bladder Cancer as Prognostic Marker | unknown | — | 50 | Technical University of MunichOTHER | 1 | Jan 18, 2012 | clinicaltrials |
| NCT01087268 | Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer | unknown | Phase 3 | 75 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jul 15, 2011 | clinicaltrials |
| NCT00633204 | Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer | unknown | Phase 2 | 150 | Iwate Medical UniversityOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT01196403 | Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer | unknown | Phase 2 | 92 | Wales Cancer Trials UnitOTHER | 1 | Apr 1, 2011 | clinicaltrials |
| NCT01082510 | Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study) | unknown | Phase 3 | 288 | Urological Oncology Council of Northern TokyoOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00962052 | Biomarker Discovery and Application in Bladder Cancer | unknown | — | 250 | Wolfson Medical CenterOTHER_GOV | 1 | Sep 14, 2010 | clinicaltrials |
| NCT01000129 | Adaptive Planning in Bladder Cancer(APPLY) | unknown | Phase 2 | 32 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 22, 2009 | clinicaltrials |
| NCT00867620 | Development of a Non-Invasive DNA Methylation-Based Assay System for the Risk Assessment of Urothelial Carcinoma | unknown | — | 82 | National Taiwan University HospitalOTHER | 0 | Mar 24, 2009 | clinicaltrials |
| NCT00126958 | Cost-Effectiveness in Bladder Cancer | unknown | — | 500 | Erasmus Medical CenterOTHER | 0 | Feb 19, 2009 | clinicaltrials |
| NCT00816075 | Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection | unknown | Phase 2 / Phase 3 | 40 | Bozyaka Training and Research HospitalOTHER | 1 | Feb 17, 2009 | clinicaltrials |
| NCT00491296 | Changes in Prostate Specific Antigen Levels During Synergo Therapy-Intravesical Chemotherapy Instillations Combined With Hyperthermia | unknown | — | — | HaEmek Medical Center, IsraelOTHER | 1 | Nov 7, 2008 | clinicaltrials |
| NCT00006118 | Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Jul 24, 2008 | clinicaltrials |
| NCT00146276 | Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer | unknown | Phase 3 | 178 | Association of Urologic Oncology (AUO)OTHER | 1 | Sep 27, 2006 | clinicaltrials |
| NCT00244205 | Identifying Methylation Biomarkers for Monitoring Bladder Tumors | unknown | — | 120 | Copenhagen University Hospital at HerlevOTHER | 1 | Nov 15, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Jan 10, 2014source: clinicaltrials